Recent Updates
Recently added Catalysts
PEN

Penumbra, Inc. Announces Participation at Upcoming Investor Conferences Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following upcoming investor conferences: Event:...

Key Takeaway: ALAMEDA, Calif. , Aug. 24, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the following upcoming investor conferences: An audio webcast of each presentation will be available by visiting the investors section

Full Press Release Details

ALAMEDA, Calif. , Aug. 24, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the following upcoming investor conferences:
Event: Wells Fargo 2017 Healthcare Conference
Location: Boston, MA at the Westin Boston Waterfront
Date: Thursday, September 7, 2017
Time: 1:40pm ET / 10:40am PT
Event: Morgan Stanley 15 th Annual Global Healthcare Conference
Location: New York, NY at the Grand Hyatt New York
Date: Wednesday, September 13, 2017
Time: 10:30am ET / 7:30am PT
An audio webcast of each presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com . The webcast will be available on the company's website for two weeks following each event.
About Penumbra, Inc. Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on interventional therapies. Penumbra designs, develops, manufactures and markets innovative devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States , most of Europe , Canada and Australia , and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc.
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

Related Links

21 %

Last updated: Aug 24, 2017